Clark Ian T. - 19 Dec 2025 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Dec 2025, 21:42:34 UTC
Prior SEC filing
08 Dec 2025
Next SEC filing
18 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Shane Kovacs, Attorney-in-fact

Key filing fact

Clark Ian T. filed Form 4 for Olema Pharmaceuticals, Inc. (OLMA) on 23 Dec 2025.

Key facts

  • This page summarizes Clark Ian T.'s Form 4 filing for Olema Pharmaceuticals, Inc. (OLMA).
  • 11 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 23 Dec 2025, 21:42.

Change

  • Previous filing in this sequence was filed on 08 Dec 2025.
  • Current net transaction value: -$6,653,566.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001336504 Primary reporting owner

CLARK IAN T

Relationship
Director
Address
C/O OLEMA PHARMACEUTICALS, INC., 780 BRANNAN STREET, SAN FRANCISCO
Signature
/s/ Shane Kovacs, Attorney-in-fact
Signature date
23 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OLMA transaction

Common Stock

Options Exercise

Transaction value
$923,894
Shares
+209,690
Change %
Price
$4.41
Shares after
209,690
Date
19 Dec 2025
Ownership
Direct
OLMA transaction

Common Stock

Options Exercise

Transaction value
$77,687
Shares
+21,520
Change %
+10%
Price
$3.61
Shares after
231,210
Date
19 Dec 2025
Ownership
Direct
OLMA transaction

Common Stock

Options Exercise

Transaction value
$168,717
Shares
+21,520
Change %
+9.3%
Price
$7.84
Shares after
252,730
Date
19 Dec 2025
Ownership
Direct
OLMA transaction

Common Stock

Options Exercise

Transaction value
$49,246
Shares
+12,070
Change %
+4.8%
Price
$4.08
Shares after
264,800
Date
19 Dec 2025
Ownership
Direct
OLMA transaction

Common Stock

Sale

Transaction value
$862,132
Shares
-29,904
Change %
-11%
Price
$28.83
Shares after
234,896
Date
19 Dec 2025
Ownership
Direct
Footnotes
F1
OLMA transaction

Common Stock

Sale

Transaction value
$5,735,694
Shares
-193,056
Change %
-82%
Price
$29.71
Shares after
41,840
Date
19 Dec 2025
Ownership
Direct
Footnotes
F2
OLMA transaction

Common Stock

Sale

Transaction value
$1,275,283
Shares
-41,840
Change %
-100%
Price
$30.48
Shares after
0
Date
19 Dec 2025
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OLMA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-209,690
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
209,690
Exercise price
$4.41
Footnotes
F4
OLMA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-21,520
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
21,520
Exercise price
$3.61
Footnotes
F4
OLMA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-21,520
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
21,520
Exercise price
$7.84
Footnotes
F4
OLMA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-12,070
Change %
-50%
Price
$0.000000
Shares after
12,080
Date
19 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,070
Exercise price
$4.08
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The weighted average sale price for the transaction reported was $28.83, and the range of prices was between $28.215 and $29.21. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

Footnote F2

The weighted average sale price for the transaction reported was $29.71, and the range of prices was between $29.22 and $30.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

Footnote F3

The weighted average sale price for the transaction reported was $30.48, and the range of prices was between $30.23 and $30.995. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

Footnote F4

Fully vested.

Footnote F5

The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 11, 2025, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .